CPJE Pertinent Flashcards

Question

Amphotericin B deoxylate

Answer 1

Amphotec>AmphoB>Abelcet>Ambisome - Class: ergosterol, fungicidal Indication/dose: yeasts, molds, dimorphic - Side Effects: hypoK, hypoMG, nephrotoxic - Notes: premedication to avoid fever, chills, hypo, nausea: APAP, NSAID, Diph, Meperidine, fluid boluses. D5W compatible only

Answer 2

- reduces risk of cold - GI/rash - avoid if allergic to ragweed, chrysanthemum, daisies

Answer 3

Soma - Muscle relaxant - 250-350mg QID prn - CIV - sedation, dizziness, confusion - avoid in elderly

Answer 4

Tekturna - Direct renin inhibitor - 150-300mg/day - CI: avoid with ACEi or ARBs in patients with diabetes; angioedema; bilateral renal artery stenosis - BBW: avoid in pregnancy - avoid in CrCl<60 - SE: hyperK, angioedema, hypotension

Answer 5

Butrans (patch) - opioid agonist - mod-sev pain pts who need ATC opioid - Apply to upper outer arm, chest, side of chest, upper back - Change weekly (do not apply to same site for at least 3 weeks), NTE: 20mcg/hour due to QT risk - Fold and throw away

Answer 6

Aldara cream - Warts (avoid sex during application, can weaken condoms) - Caused by HPV, can use also cryotherapy, electrocautery, excision - Apply to area at bedtime, rub till no longer visible (1 packet per application). 3x/week until clearance or for 16 weeks. - Wash off after 8 hours. Can cause edema, burning, erythema, itching

Answer 7

Miacalcin/Fortical - Osteoporosis and hormone therapy - Inhale 1 spray (200 IU) daily [alternate nostril daily] - MOA: inhibit osteoclastic bone resorption - CI: allergy to calcitonin-salmon - SE: rhinitis, dizzy, flu-like symptoms, dyspepsia - Unused bottle: refrigerate, room temp for opened bottle -- need to prime. if remain upright, dont need to re-prime. - After 30 sprays, should discard - Need to supplement Ca/Vit D

Answer 8

Chantix - partial a4/b2 nicotinic receptor agonist. DA stimulation as well. - reduce cravings for smoking cessation - Days 1-3: 0.5mg daily - Days 4-7: 0.5mg BID - Days 8: 1mg BID - Start 1 week before quit date - Take with food and water to reduce n/v - SE: angioedema, skin rxns, abnormal dreams, n/v - BBW: neuropsychiatric events (depression, suicide) - medguide required

Answer 9

<72 hr since exposure (known HIV+ status) Duration: 28 days NNRTi Based: - Efavirenz (NNRTi) + - Lamivudine (NRTi) or emtricitabine (NRTi) + - Zidovudine (NRTi) or tenofovir (NRTi) PI-Based: - Lopinavir/r (PI) + - Lamvudine (NRTi) or emtricitabine (NRTi) + - Zidovudine (NRTi)

Answer 10

Recommended if the source of contaminated blood or body fluid is known to be HIV positive 2 drug regimen: - Zidovudine (NRTi) or tenofovir (NRTi) + - Lamivudine (NRTi) or emtricitabine (NRTi) Truvada (emtricitabine/tenofovir) Combivir (zidovudine/lamivudine) 3 drug regimen - Zidovudine (NRTi) or tenofovir (NRTi) + - Lamivudine or emtricitabine + - Lopinavir/r (PI)

Answer 11

Rheumatrex/Trexall/Folex - Folate antimetabolite that inhibits DNA synthesis - Indications: MS, RA, cancers, psoriasis - RA: 7.5-22.5mg/week - SE: n/v, diarrhea, anorexia, skin reddening, mucositis, pulmonary toxicity - BBW: hepatotoxic, pneumonitis, bone marrow suppression, acute renal failure, malignant lymphomas, fetal death in pregnancy - High dose MTX --> leucovorin (active FA) as rescue - Notes: drink plenty of water, avoid use with NSAID's, penicillins. - Monitor: LA, TSH, CBC w/diff, BUN/Scr

Answer 12

Topamax (capsule, tablet) - Fast sodium channel blocker, blocks T-type calcium currents. Enhances GABA, antagonizes AMPA/kainate glutamate receptors - Adjunct therapy for partial seizures or conversion to primary therapy - Week 1: 25mg BID, up 25mg weekly. Max: 400mg/day - SE: Somnolence, dizziness, difficulty with memory, cognitive impairment, taste perversions, oligohydrosis, hyperthermia - Notes: infants with oral clefts to mothers on topiramate (Cat. D) - Qsymia (phentermine+topiramate ER): FDA-approved for weight loss

Answer 13

Tegretol/Carbatrol/Epitol (capsule, tablet, suspension) - seizures/trigeminal neuralgia - Initial: 200 mg BID (daily if XR) - Max: 1600 mg - Therapeutic range: 4-12 mcg/mL - BBW: Skin rxns, test asians for HLA-B1502 (+? cannot use). Fatal blood cell abnormalities (aplastic anemia and agranulocytosis) - SE: n/v, dizziness, drowsiness, HA, ataxia, speech disturbances - Monitor: LFT's, CBC, platelets, chem panel (3,6 months, annually)

Answer 14

Mefoxin (IV) - 1-2g q6-8h - 2nd Gen. Ceph: Some G+, HNPEK, B. fragilis - CrCL>50: no changes - HD: 500mg to 1g q24-48h, give supplemental dose after each dialysis (1 to 2 gram), then give MD - Notes: cross sens to PCN (<10%), reduce in renal impairment - SE: anaphylaxis, GI upset, seizures with accumulation, raise in LFTs, bone marrow suppression

Answer 15

- Contact precautions - Pneumovax (prevnar: 6 weeks, pneumovax: 2 years). Routine: younger than 2years (2, 4, 6 and 12-15 months). 1 dose for all children (14-59 months). 1 single supplemental dose for children (60-71 months) - Masks

Answer 16

Evamist transdermal spray - moderate to severe vasomotor symptoms (hot flashes) due to menopause - each spray (90 mcL = 1.53 mg of estradiol) - apply to forearm just below the elbow (do not apply to breast), let dry for at least 2 minutes, do not wash for at least 30 minutes - prime, avoid grapefruit, do not use sunscreen at the same time. Store at room temp - SE: chest pain, numbness, vaginal bleeding, jaundice, swollen breasts, weight gain - DDi: StW, blood thinner, ritonavir

Answer 17

Restasis - Dry eyes (RX) - 1 drop to each eye twice daily - SE: burning, stinging, redness, blurred vision - requires medguide: use immediately after opening. don't touch tip to eye, remove contact lenses (separate by 15 min)

Answer 18

Talwin (50mg/0.5mg) - CIV (mod to severe pain) - Pentazocine (opiate), Naloxone (prevents misuse) - 1 tab q3-4h (NTE: 12/day) - SE: HTN, hypotension, tachy, syncope

Answer 19

Micardis - ARB (block AT2 from binding AT1 receptors on SM) - 40-80mg/daily - SE: hyperK, angioedema (d/c if occurs), hypotension - Avoid use with aliskaren when (CrCl<60)

Answer 20

Rocephin - 3rd gen ceph: HNPEKS (Serratia) - 1-2g q12-24h (IV/IM) - only ceph dosed once daily - hepatically cleared - y-site biliary sludging with ca-solutions, separate!

Answer 21

Pradaxa (75 or 150 mg capsules) - Direct thrombin inhibitor - reduce risk of stroke and embolism is patient with non-valvular Afib - 150 mg BID - 75 mg BID (CrCl: 15-30) - 4 months expiration after bottle is opened - CI: active bleed - SE: gastritis, bleeding - if switching from warfarin: d/c warfarin, start pradaxa when INR<50) - avoid use with rifampin or other p-gp inducers

Answer 22

Singulair - Asthma - leukotriene-receptor antagonists (LTRA) - D4. reduce airway edema, constriction and inflammation - 10 mg in the evening - 12mo-5 years: 4 mg daily - 5-14 years: 5 mg daily - SE: HA, dizzy, abd pain, LFTs, upper resp tract - Cat. B

Answer 23

Epogen/Procrit - IV/SC - Anemia - Erythrocyte stimulating agent (ESA) - 150 U/kg SC TID per week - or 40,000 U SC weekly - BBW: patient needs medguide, prescribers need to comply with APPRISE program - SE: myalgia, arthralgia, cough, bone pain, hypoK - CI: *UNCONTROLLED HTN

Answer 24

Isentress - Integrase Inhibitor: block enzyme needed for viral DNA to enter host nucleus - 400 mg BID - SE: rise in CPK, muscle weakness, rhabdo - metabolized by UGT1A1-mediated glucoronidation, rifampin is an inducer (concomitant use will reduce levels of raltegravir)

Answer 25

Oleptro (ER) - Depression/insomnia - 5-HT reuptake inhibitor and a1-blocker and histamine blocker - 100-150 mg BID - SE: sedation, orthostasis, priaprism

Answer 26

Requip - DA agonist (similar to DA at DA receptor) - Parkinson's disease - Start: 0.25 mg TID, titrate weekly to 1-4 mg TID - XL: start 2 mg daily, max 24 mg/daily - SE: drowsiness, daytime sleep attacks, hallucinations, dyskinesias, orthostasis

Answer 27

Kadian/Avinza - opioid - ER: dosed q8-12h

Answer 28

Ziac - 2.5/6.25 - 5/6.25 - 10/6.25

Answer 29

Solu-Medrol - Gout - Intra-articular injection

Answer 30

Avodart - BPH - 5-a reductase inhibitor - 0.5 mg soft gel daily - SE: dec. libido, impotence, breast tenderness - Notes: 6 mo's for max effect, PSA levels will dec.

Answer 31

Lovenox - Px of VTE: 30 mg SC q12h or 40 mg SC daily, 30 daily (CrCl<75 years: 30 mg IV bolus plus 1 m/k SC dose followed by 1 m/k q12h (max: 100 for the first 2 doses). 1 m/k SC daily - PCI: if 8 hrs past since last dose and before inflation, give 0.3 m/k IV bolus. Monitor: Anti-Xa - SE: bleeding, thrombocytopenia, anemia - LMWH interchange: Dalteparin (Fragmin) - VTE proph/TX of UA+NSTEMI, Tinzaparin - HIT: hep antibody bind to platelets, plt drop of 50%+ from baseline (normal: 150-450k/ul) tx: Bivali (Angiomax), Argatroban, Lepi (Refludan)

Answer 32

Symlin - SymlinPen 120 or 60 - Vial: 0.6 mg/ml (5ml) - Diabetes 1 and 2 - synthetic analog of amylin (assist postprandial glucose control, slow gastric emptying, prevents increase in serum glucagon following a meal, and increases satiety) - 1: start at 15 mcg prior to meals (up to 60 mcg) - 2: start at 60 mcg (up to 120) - SC injection (abdomen, thigh) prior to each meal (>250 kcal or >30 g of carbs) - SE: hypoglycemia (reduce mealtime insulin by 50%), nausea, anorexia, weight loss

Answer 33

Neoral/Sandimmune - cannot interchange: modified (Gengraf/neoral) has more bioavailability than non-modified (Sandimmune) - SE: HTN, hirsuitism, g. hyperplasia, hyperTRIG, nephropathy

Answer 34

- inhibit HIV-1 protease and rendering the enzyme incapable of cleaving gag-pol = immature virions (#7) - SE: hyperglycemia, insulin resistance, lipodystrophy, loss of SC fat in face/butt/arms/legs, lipohypertrophy (fat accumulation in various areas of the bod, dyslipidemia, hepatitis, Immune reconstitution syndrome

Answer 35

Trilipix 45 or 135 mg Antara 43 or 130 mg TriCor 48 or 145 mg - peroxisome receptor alpha (PPARa) activators = enhanced elimination and dec synthesis of VLDL causing TG to decrease and HDL to increase = increase in apolipoprotein lipase = dec LDL - when TG's are high --> TG reduce and LDL may increase - monitor: LDL, LFT, renal function - SE: LFT inc, CPK inc, myopathy, abd pain, rhabdo with statins - Notes: Trilipix has indication with statin, may have similar SE profile. Gemfibrozil may inc risk of myopathy

Answer 36

Zegerid/OTC (20, 40mg caps with 1.1g of NaBicarb) Powder: 20, 40 with 1.68g of NaBicarb Tabs: 20, 40 with 750 NaBicarb/343 MgOH - PPI - Notes: onset of relief is 2-3 hours and lasts 12-24 hours - SE: HA, dizzy, constipation, hypoMg, risk of Cdiff, osteoporosis, inc INR

Answer 37

Protonix - PPI - 20, 40mg tabs - Granules for susp 40mg/pk - inj (40mg IV)

Answer 38

Advair (diskus or HFA) - LABA+ICS - Disk: 1 inh BID - HFA: 2 inh BID Strengths: HFA -- Diskus - (230/21) -- (500/50) - (115/21) -- (250/50) - (45/21) -- (100/50)

Answer 39

- Direct vasodilator - vasodilation of arterioles, no effect on veins - SE: LUPUS-LIKE REACTION (fever, joint/muscle aches, fatigue), reflex tachycardia

Answer 40

Cancidas - Echinocandins - DOC: Candida - LD: 70 mg IV day 1 - then 50 mg daily - COMPATIBLE WITH NS ONLY - SE: LFT's, hypotension - Note: once daily and no requirement for dose adjustment in renal impairment

Answer 41

Reyetaz - Protease inhibitor (#7) - TAKE WITH FOOD (better absorption) - hyperbilirubinemia, rash, nephrolithiasis - do not take with antacids (2/1 hours) - 12 hours before PPI's

Answer 42

Primaxin - Carbapenems - 250-1000 mg IV q6-8h - G+, G-, anaerobes, Pseudomonas - SE: diarrhea, rash, seizures with higher doses/renal impairment - LOWER DOSE IN RENAL PATIENT - avoid in pcn allergy (10-50% cross reactivity)

Answer 43

NicoDerm CQ/Habitrol (OTC or Rx) >10 = 21mg/day patch <10 = 14mg/day patch - SE: skin reactions, insomnia, VIVID DREAMS - start on morning of quit date - wear 16hrs to avoid insomnia, try to wear for 24hr - neck and waist application (hairless location) - DO NOT SMOKE CIGS CONCURRENTLY

Answer 44

Prevnar (conjugate) = 2 months Pneumovax = 2+ years - VACCINATE: infants (n<2), 65+, 19-64 if smoke or asthma, 2-64 chronic illness (sickle cell, immune compromised, asplenia) - revaccinate: all adults every 5 yrs if at risk

Answer 45

``` Varicella (SC) - VAR: Varivax (chicken pox) - ZOS: Zostavax (herpes zoster/shingles) SHINGLES: - FDA (50 years of age or older), ACIP (60+) ``` - live vaccines! avoid in immunecompromised and pregnancy - use within 30 min of reconstitution - avoid if allergic to geletin or neomycin

Answer 46

Lamisil - tinea unguium (onychomycosis) - Fingernail: 250 mg daily (6 weeks) - Toenail: 250 mg daily (12 weeks) - SE: diarrhea, loss of taste, vision changes - may cause liver disease, w/wo food

Answer 47

- monitor: BUN, Scr, renal function (dig/amik), pancreatitis (amylase/lipase)

Answer 48

Zosyn - 40+ = 3.375q6h - 20-40 = 2.25q6h - <20 = 2.25q8h

Answer 49

- pneumococcal and influenza

Answer 50

Januvia - DPP4-inhibitors (incretin enhancers): prevent DPP-4 enzyme -- prevent breakdown of incretin, glucagon-like peptide, and GIP. regulate blood glucose levels by inc insulin release and dec. glucagon secretion - 100 mg daily (can start at 50 mg) - 25 mg with CrCl < 30, including dialysis Goals: A1C < 7 pre 70-130 post (1-2hrs) < 180

Answer 51

Catapres-TTS Patch - centrally acting alpha-2 agonist (Guanabenz, Guanfacine, Methyldopa) - APPLIED WEEKLY - Dose: 0.1, 0.2, 0.3 mg/24hr - apply to upper, outer arm, upper chest - use white round cover - SE: rebound HTN if stopped abruptly, bradycardia, dry mouth, ortho hypotension, psych reactions

Answer 52

- 84 active, 7 placebo - 3 month birth control - Seasonale = placebo 7 days - Seasonique = Low estrogen (7 days) - Start: sunday after period starts even if still bleeding (b/u 7days)

Answer 53

- APPLY MONTHLY - in for 3 weeks, out for 1 week - start: day 1-5 from menses - week 1: out 3+ hrs --> rinse cool water, reinsert, B/U! for 7 days -- EC if sex within 5 days - week 2/3: out 3- hrs, rinse + insert - week 2/3: out 3+ hrs, rinse + insert (B/U!) - 1st cycle = B/U - RT for 4 months

Answer 54

Toradol - nsaid (non-selective) - short-term mod-severe acute pain - 10-20 mg oral - comes in IV, IM, nasal spray - 5 DAY MAX TREATMENT - avoid in bleeding risk, start with inj switch to oral

Answer 55

LDL < 100 = CHD RE with 20%+, DM < 100 LDL < 130 = 2+ RF with 10-20% LDL < 130 = 2+ RF with < 160 = 0-1 RF

Answer 56

Lipitor 10-80 mg daily +amlo (Caduet) DDI: CYP3A4 metabolism (less than lova/simva). 3A4 inh will inc concentration. - avoid greater than 20 mg: itraconazole, clarithromycin

Answer 57

Plavix - MOA: P2Y12 inhibitor. Bind P2Y12 on platelets, prodrug and bind IRR to receptor --> block platelet activation/aggregation - needs 2C19 activation to active metabolite. 2C19*2/3 = poor metabolizers - SE: bleeding, bruising, rash, TTP (purpura - fever, weakness, paleness) - CI: active bleeding - d/c 5 days prior to major surgery

Answer 58

EFFIENT ``` LD: 60 mg daily MD: 10 mg daily n block platelet activation/aggregation - reduction of thrombolytic events in pts w/ACS managed with PCI - Not rec in pts > 75 - d/c 7 days prior to surgery ```

Answer 59

Cymbalta - SNRI's - depression, nerve pain, fibromyalgia - 20, 30, 60 mg - SE: sexual dysfunction, N/V, BP inc, constipation - DDI: maoi's, 2D6 inhibitors (TRAMADOL - 5ht-x)

Answer 60

Zoloft - SSRI - 50-200 mg/day - use for depression, PMDD (2 weeks prior to menses), OCD - comes in liquid (20mg/ml) - 2 weeks for energy - 4-6 WEEKS FOR MOOD SE: sexual, GI, anorgasm, ejaculation diff, akathisia, insomnia, poor concentration, fatigue

Answer 61

Depakene, Divalproex, Depakote - epilepsy, seizures - TR: 50-100, low albumin increase VPA levels - BBW: hepatic failure, teratogenicity, pancreatitis - SE: GI, abd pain, dizzy, ALOPECIA (supplement with selenium and zinc), thrombocytopenia,

Answer 62

Detrol, Detrol LA - Overactive bladder - 1-2 mg bid or 2-4 mg daily - muscarinic receptor antagonist compete with ACH, blocking the contraction of detrusor muscle - SE: dry mouth, constipation, dry/eyes (need to verify if have GLAUCOMA), urinary retention - other drugs in class: Oxybutynin (Ditropan), Trospium (Sanctura), Enablex, Toviaz, Vesicare

Answer 63

Very high: Clobetasol 0.05% (Clobex), Halobetasol 0.05% (Ultravate) High: Betamethasone 0.05% (Diprolene), oint = very high High-medium: Fluocinonide 0.05% (Lidex), gel/oin/cream = high Medium: Mometasone 0.1% (Elocon), oint = high Lower: Fluocinolene 0.01%, Desonide 0.05% (DesOwen) Mild: Aclomethasone 0.05% Lowest: Hydrocortisone 1/2.5% Clob/Halo > Betam/Fluoc/Mom > Desonide > Hydrocortisone

Answer 64

Treatment of ulcers - 1 tab 2-3x daily - Class: anticholinergic MG: is an autoimmune neuromuscular disease leading to fluctuating muscle weakness and fatigability. It is an autoimmune disorder, in which weakness is caused by circulating antibodies that block acetylcholine receptors at the postsynaptic neuromuscular junction,[1] inhibiting the excitatory effects of the neurotransmitter acetylcholine on nicotinic receptors throughout neuromuscular junctions. Myasthenia is treated medically with acetylcholinesterase inhibitors or immunosuppressants

Answer 65

Report to DEA/BOP within 14 days

Answer 66

Need: | physician protocol, DEA#

Answer 67

- testosterone | - soma

Answer 68

The prescriber’s signature and the date written are required to be written by the prescriber. Everything else can be written by the prescriber or his or her agent. Therefore, the pharmacist can make changes to any other information on the prescription as long as the pharmacist verifies the change with the prescriber first.

Answer 69

Business Code 4005(b) - allows written and oral prescriptions from out-of-state prescribers. Pharmacies must verify the prescription. The pharmacist should use his or her best professional judgment when filling out-of-state prescriptions.

Answer 70

Can still fill, need to write: 11167 exemption on Rx. - 11167 exemption allows: 1. emergency cases (failure to fill = loss of life or intense suffering 2. Written orders = signed and dated by prescriber 3. Reduce oral/faxed Rx's to hard copy form 4. Prescriber needs to provide appropriate Rx by 7 days --> if not, we have 144 hours to report to Bureau of Narcotic Enforcement (date/method of notification)

Answer 71

Yes. As long as the new prescription form has the statement at the bottom that reads, “Void if the number of drugs is not noted” and a line provided for the physician to write in the number of drugs prescribed

Answer 72

Pharmacies are required to keep a separate record in the pharmacy of Schedule II prescriptions filled regardless of whether or not the prescription includes other non-Schedule II medications. Additionally, the pharmacy is required to submit the Schedule II prescription information to CURES electronically or on disk, and effective January 1, 2005, must submit both Schedule II and III prescription information to CURES.

Answer 73

Yes. Have to reduce to oral prescription, retain for at least 3 years - be sure to verify the validity of the Rx prior to dispensing - electronic? need e-sig

Answer 74

Since January 1, 2004, prescriptions for all controlled substances (Schedules II–V) are valid for 6 months from the date written.

Answer 75

Yes, prescribers can fax or phone in a prescription for a Schedule III – V controlled substance. However, a security feature on the new tamper-resistant security prescription form prints VOID across the face of the prescription when faxed, please use a regular prescription form for faxed prescriptions. Pharmacies will have to validate the faxed prescriptions.

Answer 76

Yes, so long as the prescription conforms to the requirements for controlled substance prescriptions in the state in which the controlled substance was prescribed. The prescription must be delivered to the patient in the other state. Prescriptions for Schedule II controlled substances must be reported to CURES and effective January 1, 2005, prescriptions for both Schedule II and III must be reported to CURES.

Answer 77

Pursuant to Health and Safety Code section 11161.5 et seq., the approved security printer is required to verify that the prescriber ordering the new tamper-resistant security prescription forms, holds a valid unexpired license and has the authority to write controlled substance prescriptions (any or all Schedules II - V). If a pharmacist is concerned that a prescriber is not authorized to specifically write a Schedule II controlled substance prescription, the board recommends that the pharmacist ask the prescriber to provide a copy of his or her DEA registration, which lists the schedules of controlled substances that he or she is authorized to prescribe.

Answer 78

- only for CII's | - 1/1/05 - CIII-CIV for terminally ill must be on security prescription form, telephoned, faxed in to pharmacy

Answer 79

- can correct - need hardcopy mailed/faxed within 7 days with corrections - cannot touch sig and date

Answer 80

- employees can with direction | - telephoned Rx must be received by intern or pharmacist

Answer 81

- No. Two exceptions: 1. licensed skilled nursing facility, licensed inter. care facility, licensed home health agency, or licensed hospice - can call in an order or send a fax Rx for II-V substances --> need to reduce to hard copy form (sign/date - Health and safety code 11167.5). 2. Loss of life or intense suffering without meds - prescriber can phone in Rx/or fax -- reduce to hard copy. Prescriber must provide written Rx on new security forms within 7 days -- pharmacist will notify Bureau of Narcotic Enforcement within 144 hours if prescriber does not do it

Answer 82

A prescriber or pharmacist can download a Patient Activity Report (PAR) request form by clicking on one of the following links: prescriber - http://caag.state.ca.us/bne/pdfs/BNE1176.pdf pharmacist - http://caag.state.ca.us/bne/pdfs/BNE1177.pdf Complete the appropriate PAR form and fax it to the Department of Justice, Bureau of Narcotic Enforcement at (916) 227-5079.

Answer 83

Yes. A physician who administers or dispenses controlled substances directly to their patients in the office, pursuant to Business and Professions Code section 4170, are required to have a separate DEA registration number for every address from which he or she practices. If the physician only writes prescriptions for their patients to take to a pharmacy to dispense, then he or she is only required to have one DEA number for all practice addresses.

CPJE Pertinent Flashcards

(107 cards)